Targeting the Toll-Like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.02.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search